NPPA Sets New Retail Prices for 30 Essential Drugs Including Vitamin D3 and Calcium Supplements
NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements
Image: Business Standard
The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 drug formulations, including Vitamin D3 and calcium supplements, under the Drugs (Prices Control) Order, 2013. Prices exclude GST and cover various chronic condition treatments, with specific prices for each formulation.
- 01Vitamin D3 Oral Solution (60,000 IU) is priced at ₹14.91 per ml.
- 02Atorvastatin and Fenofibrate tablets for lipid management are set at ₹18.46 each.
- 03The NPPA has fixed prices for diabetes medications, including a combination of Empagliflozin, Sitagliptin, and Metformin at ₹14.88 per tablet.
- 04Manufacturers must submit updated price lists via the Integrated Pharmaceutical Database Management System (IPDMS).
- 05Any overcharging by manufacturers will lead to penalties under the DPCO, 2013.
Advertisement
In-Article Ad
The National Pharmaceutical Pricing Authority (NPPA) has announced the retail prices for 30 drug formulations, including Vitamin D3 oral solution and various calcium and vitamin supplements, as part of its regulatory mandate under the Drugs (Prices Control) Order (DPCO), 2013. The prices set by the NPPA are exclusive of Goods and Services Tax (GST) and apply to manufacturers and marketing companies specified in the notification. Notable pricing includes Vitamin D3 Oral Solution at ₹14.91 per ml, Atorvastatin and Fenofibrate tablets at ₹18.46 each, and Tacrolimus Prolonged Release Capsules at ₹127 per capsule. The NPPA has emphasized that manufacturers must determine pack prices based on these approved rates and submit updated price lists through the Integrated Pharmaceutical Database Management System (IPDMS). Retailers are required to display these prices prominently. The authority has warned that any manufacturer charging above the approved prices will face penalties, including the requirement to refund the overcharged amounts with interest. This notification supersedes all previous price orders for the specified drugs.
Advertisement
In-Article Ad
The new pricing structure will directly affect the cost of essential medications for consumers, particularly those with chronic conditions.
Advertisement
In-Article Ad
Reader Poll
How do you feel about the new drug pricing regulations?
Connecting to poll...
More about National Pharmaceutical Pricing Authority
Read the original article
Visit the source for the complete story.